The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years

This publication has 102 references indexed in Scilit:

• Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
  BMC Cancer, 2012
• Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
  BMC Cancer, 2011
• Progesterone Receptor Membrane Component 1 Inhibits the Activity of Drug-Metabolizing Cytochromes P450 and Binds to Cytochrome P450 Reductase
  Molecular Pharmacology, 2011
• Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
  Molecular and Cellular Biology, 2010
• Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity
  Journal of Biological Chemistry, 2010
• Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
  Cancer Cell International, 2009
• Heterologous expression of human mPRα, mPRβ and mPRγ in yeast confirms their ability to function as membrane progesterone receptors
  Steroids, 2008
• Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors
  Molecular Endocrinology, 2008
• Mifepristone Inhibits Ovarian Cancer Cell GrowthIn vitroandIn vivo
  Clinical Cancer Research, 2007
• Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells
  Molecular and Cellular Biology, 2007